Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
6.92
+0.29 (4.37%)
Jul 10, 2026, 3:45 PM EDT - Market open
Cybin Market Cap
Cybin has a market cap or net worth of $428.93 million as of July 10, 2026. Its market cap has increased by 146.86% in one year.
Market Cap
428.93M
Enterprise Value
253.08M
1-Year Change
146.86%
Ranking
Category
Stock Price
$6.92
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $428.93M, an increase of 370.86%. That is a compound annual growth rate of 31.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 428.93M | 5.08% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 414.59M |
| Puma Biotechnology | 413.81M |
| Adlai Nortye | 407.20M |
| Vanda Pharmaceuticals | 395.69M |
| Abeona Therapeutics | 387.57M |
| Vicore Pharma Holding AB | 386.95M |
| Atea Pharmaceuticals | 384.93M |
| Larimar Therapeutics | 376.82M |